Trial · NCT05018286
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse events (AE) | From baseline to week 208 | System organ class, frequency and severity |
| Primary | Clinical chemistry | From baseline to week 208 | Clinical Chemistry panel of analytes will be examined for clinically significant changes. |
| Primary | Hematology | From baseline to week 208 | Hematology panel of analytes will be examined for clinically significant changes. |
| Primary | Hemostasis | From baseline to week 104 | Hemostasis INR will be examined for clinically significant changes. |
| Primary | Urinalysis | From baseline to week 208 | Urinanalysis panel of analytes will be examined for clinically significant changes. |
| Primary | Occurrence of clinically relevant changes in vital signs | From baseline to week 208 | * Systolic and diastolic blood pressure in mmHg will be examined for clinically significant changes. * Heart rate in Beats per Minute (BPM) will be examined for clinically significant changes. |
| Primary | Occurrence of clinically relevant changes in electrocardiogram | From baseline to week 208 | ECG; intervals and rhythm |
| Secondary | Change from baseline in PS volume | From baseline to week 208 | |
| Secondary | Change from baseline in PS frequency | From baseline to week 208 | Change in PS days/week from baseline to week 104 |
| Secondary | Clinically significant changes in PS total energy | From baseline to week 208 | Units: kcal |
| Secondary | Change from baseline in PS infusion time | From baseline to week 208 | |
| Secondary | Percentage of subjects reaching enteral autonomy | From baseline to week 104 | |
| Secondary | Change from baseline in body weight | From baseline to week 104 | Units: kg |
| Secondary | Change from baseline on the Patient Global Impression of Severity (PGIS) | From baseline to week 104 | |
| Secondary | Change from baseline on the Pittsburgh Sleep Quality Inventory (PSQI) | From baseline to week 208 | |
| Secondary | Change from baseline on the Patient Global Impression of Change (PGIC) | From baseline to week 208 | |
| Secondary | Changes from baseline on Patient Global Impression of Treatment Satisfaction (PGI-TS) | From baseline to week 208 | |
| Secondary | Changes from baseline on Patient Global Impression of Satisfaction with Parenteral Support (PGI-SPS) | From baseline to week 208 | |
| Secondary | Changes from baseline on Patient Global Impression of Parenteral Support Impact (PGI-PSI) | From baseline to week 208 | |
| Secondary | Change from baseline on the Short Form (36) Health Survey (SF-36) | From baseline to week 208 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05018286/registered